Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate

Not yet recruitingOBSERVATIONAL
Enrollment

365

Participants

Timeline

Start Date

October 31, 2018

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2026

Conditions
Spina BifidaUrothelial NeoplasmBladder, NeurogenicBladder ExstrophyHypospadias
Interventions
PROCEDURE

Transurethral Resection of Prostate

Transurethral resection of the prostate is a urological operation used to treat benign prostatic hyperplasia (BPH). It is performed by visualising the prostate through the urethra and removing tissue by electrocautery or sharp dissection with a resectoscope. This is considered the most effective treatment for BPH. This procedure is done with spinal or general anaesthetic. A triple lumen catheter is inserted through the urethra to irrigate and drain the bladder after the surgical procedure is complete. Outcome is considered excellent for 80-90% of BPH patients.

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT03698721 - Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate | Biotech Hunter | Biotech Hunter